Dynamic mobility of concentrated suspensions. Comparison between different calculations

Literature Information

Publication Date 2004-03-10
DOI 10.1039/B312839C
Impact Factor 3.676
Authors

F. J. Arroyo, F. Carrique, S. Ahualli, A. V. Delgado


View Original

Abstract

One of the fields where electroacoustic techniques (electrokinetic sonic amplitude, ESA, and colloid vibration current, CVI, are presently available) are expected to be most useful is concentrated suspensions. Here, other electrokinetic techniques, linked to the observation of individual particles, show great limitations. In spite of this, the problem of electroacoustics in concentrated suspensions is far from being fully resolved. In this work, the method considered is ESA, where the quantity of interest is the dynamic or ac mobility of the particles, ud*. Our aim is to compare in a systematic way two procedures for the calculation of ud* in concentrated suspensions: One is based upon the use of a cell model, often used in electrokinetics of concentrated systems, and the other is an analytical formula elaborated by O'Brien and coworkers taking explicitly into account particle–particle interactions. On the average both methods seem to describe properly the frequency dependence of ud*, at least up to volume fractions of solids of the order of 40%. Maxima and minima are sometimes found that can be explained through consideration of electrical double layer relaxations (alpha and, mainly, Maxwell–Wagner–O'Konski) affecting the strength of the dipole moment induced by the external field. As to the effect of κa (a: particle radius; κ: reciprocal double layer thickness) on ud*, it is found that the analytical formula, in spite of being a “large κa” model can be used with confidence down to κa ∼ 10. The two methods can also predict the reduction in |ud*| upon increasing volume fraction, but only the cell model suggests that the phase angle of |ud*| goes to zero when the particle-to-particle distance is very much reduced (highest volume fractions). It appears that the phase angle can be very sensitive to the different ways in which the methods used account for the interactions between neighbouring particles, as no significant differences are found when the effect of the volume fraction (or the zeta potential) on |ud*| are estimated using any of the models.

Related Literature

Correction: Synthesis of highly substituted 2-spiropiperidines

Samuel D. Griggs, Nathan Thompson, Daniel T. Tape, Marie Fabre, Paul A. Clarke

2018-08-10 Correction

DOI: 10.1039/C8OB90117A

Synthesis of functionalized 2,5-dihydropyrrole derivatives via a convenient [3 + 2] annulation of azomethine ylides with allenoates

Zhusheng Huang, Zonghao Dai, Jin Zhu, Fulai Yang, Qingfa Zhou

2018-08-28 Communication

DOI: 10.1039/C8OB01946K

Radical addition to oximeethers for asymmetric synthesis of β-amino acid derivatives

Hideto Miyabe, Kayoko Fujii, Takeaki Naito

2002-12-16 Paper

DOI: 10.1039/B208823A

One-pot synthesis of polyfunctionalized quinolines via a copper-catalyzed tandem cyclization

Dianpeng Chen, Xuejun Sun, Yingying Shan, Jinmao You

2018-09-28 Paper

DOI: 10.1039/C8OB02078G

Functionalization of diazotetronic acid and application in a stereoselective modular synthesis of pulvinone, aspulvinones A–E, G, Q and their analogues

Amarender Manchoju, Ritesh A. Annadate, Lise Desquien, Sunil V. Pansare

2018-08-10 Paper

DOI: 10.1039/C8OB01511B

Inside front cover

2022-02-01 Cover

DOI: 10.1039/D2QO90009B

Inside front cover

Cover

DOI: 10.1039/C8OB90129E

Tuning the biomimetic performances of 4-hydroxyproline-containing cyclic peptoids

R. Schettini, C. Costabile, G. Della Sala, J. Buirey, M. Tosolini, P. Tecilla, M. C. Vaccaro, I. Bruno, F. De Riccardis, I. Izzo

2018-08-27 Paper

DOI: 10.1039/C8OB01522H

Synthesis of 2-trifluoromethylquinolines through rhodium-catalysed redox-neutral [3 + 3] annulation between anilines and CF3-ynones using traceless directing groups

Haichao Huang, Hailong Wang, Chao Gong, Zhenjing Zhuang, Wenmin Feng, Si-Hai Wu, Lianhui Wang

2021-11-29 Research Article

DOI: 10.1039/D1QO01478A

You might also like

Compound Q&A

Is 6-(3-Fluorophenyl)picolinic acid (CAS: 887982-40-3) safe?

6-(3-Fluorophenyl)picolinic acid is generally considered safe for laboratory use...

887982-40-36-(3-Fluorophenyl)pi...
Compound Q&A

What industries use (3R)-3-Pyrrolidinol (CAS: 2799-21-5)?

(3R)-3-Pyrrolidinol is used in the pharmaceutical industry as a precursor for dr...

2799-21-5(3R)-3-Pyrrolidinol
Compound Q&A

What precautions should be taken when handling (4R,5R)-4,5-Diethoxycarbonyl-2,2-dimethyldioxolane (CAS: 59779-75-8)?

When handling (4R,5R)-4,5-Diethoxycarbonyl-2,2-dimethyldioxolane (CAS: 59779-75-...

59779-75-8(4R,5R)-4,5-Diethoxy...
Compound Q&A

How is 1-(6-Chloroimidazo[1,2-b]pyridazin-3-yl)ethanone (CAS: 90734-71-7) typically synthesized?

1-(6-Chloroimidazo[1,2-b]pyridazin-3-yl)ethanone is often synthesized via a mult...

90734-71-71-(6-Chloroimidazo[1...
Compound Q&A

What is the market or research trend for N-Ethyl-3,4-dimethylbenzylamine (CAS: 39180-83-1)?

The market for N-Ethyl-3,4-dimethylbenzylamine (CAS: 39180-83-1) remains steady,...

39180-83-1N-Ethyl-3,4-dimethyl...
Compound Q&A

What is Tert-butyl 3-(pyrrolidin-1-yl)azetidine-1-carboxylate (CAS: 1019008-21-9)?

Tert-butyl 3-(pyrrolidin-1-yl)azetidine-1-carboxylate is a chemical compound wit...

1019008-21-9Tert-butyl 3-(pyrrol...
Compound Q&A

What regulatory guidelines apply to 1-Bromo-3-chloro-2,4-dimethoxybenzene (CAS: 1228956-93-1)?

1-Bromo-3-chloro-2,4-dimethoxybenzene (CAS: 1228956-93-1) falls under the classi...

1228956-93-11-Bromo-3-chloro-2,4...
Compound Q&A

Is 8-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one (CAS: 1368622-07-4) safe?

The safety of 8-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one (CAS: 1368622-07...

1368622-07-48-Bromo-2-methyl-3,4...
Compound Q&A

Is Benzyl [(3S)-2,6-dioxo-3-piperidinyl]carbamate (CAS: 22785-43-9) safe?

Benzyl [(3S)-2,6-dioxo-3-piperidinyl]carbamate is generally safe when handled wi...

22785-43-9Benzyl [(3S)-2,6-dio...
Compound Q&A

How should 1-{[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]sulfonyl}pyrrolidine (CAS: 928657-21-0) be stored?

1-{[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]sulfonyl}pyrrolidine s...

928657-21-01-{[4-(4,4,5,5-Tetra...

Source Journal

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
Self-citation Rate: 10.3%
Articles per Year: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.